Page last updated: 2024-08-24

pyrazolo(3,4-d)pyrimidine and Liver Neoplasms

pyrazolo(3,4-d)pyrimidine has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Botta, M; Brai, A; Cianciusi, A; D'Antona, L; Dreassi, E; Fallacara, AL; Iovenitti, G; Mancini, A; Marianelli, S; Molinari, A; Perrotti, N; Rango, E; Schenone, S; Trivisani, CI; Zamperini, C	1

Other Studies

1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Liver Neoplasms

Article	Year
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma. European journal of medicinal chemistry, 2021, Nov-05, Volume: 223 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Stability; Female; Fibrinolysin; Half-Life; Humans; Immediate-Early Proteins; Liver Neoplasms; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Prodrugs; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Transplantation, Heterologous	2021

Article

Year

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.

European journal of medicinal chemistry, 2021, Nov-05, Volume: 223

Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Stability; Female; Fibrinolysin; Half-Life; Humans; Immediate-Early Proteins; Liver Neoplasms; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Prodrugs; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Transplantation, Heterologous

2021